North America Artificial Disc Market Value was valued at USD 874.1 million in 2019 and is expected to witness over 19% CAGR from 2019 to 2026.

Get more details on this report - Request Free Sample PDF

Rising prevalence of degenerative disc diseases and other orthopaedic disorders will stimulate the adoption rate of artificial disc surgeries across North America. According to the National Institute of Health (NIH), the American population aged 65 years and above is projected to reach 88 million by 2050. The growing geriatric population base, prone to various bone related disorders such as lower back pain, osteoporosis, Paget’s diseases, rheumatoid arthritis, osteoarthritis and others will increase the adoption of artificial disc surgeries over the forthcoming years.

Technological innovations such as multi-level disc replacement surgery for treating complex bone diseases will positively impact the North America artificial disc industry growth. The multi-level artificial discs are used in patients with more than one damaged spinal disc. These surgeries provide long term relief and offer ease of movement. Moreover, such modern procedures ensure easier disc implantation and reduced risk of re-operation. Aforementioned factors will thus upsurge the demand for artificial discs during the upcoming years.

North America Market Share, By Type

Cervical artificial disc replacement segment held around USD 600 million revenue in 2019. Cervical artificial disc increases mobility and reduces stress on the adjacent disc, thus increasing patient preference towards these procedures. The surgery involves fusion of two vertebrae in order to reduce the pain and ensure patient’s accessible movement. The minimally invasive cervical disc replacement procedure reduces the risk of infections and re-operation. Such factors will thus augment the demand for cervical artificial discs over the forecast period.

North America Market Value, By Material

Metal-on-metal segment is projected to show 18% CAGR throughout the analysis timeline. The doctors and clinicians prefer metal-on-metal implants due to its longevity. The widely used metal implants are cobalt-nickel-chromium-molybdenum and chromium-cobalt-molybdenum, titanium alloys, tantalum and zirconium alloys, due to its high corrosion resistant property. Furthermore, low cost of metal-on-metal implants than metal-on-biopolymers will further augment the product adoption in emerging economies.

North America Market Size, By Country

U.S. artificial disc market is poised to exceed USD 2.5 billion by 2026 owing to growing burden of orthopaedic diseases in the country. Adoption of sedentary lifestyle has led to increasing prevalence of degenerative disc disorders and bone diseases. According to the Centers for Disease Control and Prevention (CDC), around 54 million adults in the U.S. were diagnosed with arthritis in 2015. Technological advancements and rising healthcare expenditure will further drive the U.S. artificial disc market over the forecast timeframe.

Competitive Market Share

Some of the major industry players involved in North America Artificial Disc market include AxioMed, Medtronic, Globus Medical, NuVasive, DePuy Synthes, Paradigm Spine, Spineart, Synergy Disc Replacement, Zimmer Biomet and others. The companies are adopting various strategies such as collaborations, acquisitions and novel product development to enhance their market position. For instance, in March 2018, Orthofix International N.V. announced acquisition of Spinal Kinetics Inc. This acquisition enabled Orthofix to broaden its spine fixation product portfolio.

Industry Background

Artificial disc replacement is a surgical procedure used for replacement of degenerated spinal column or disc. The first artificial disc surgery was performed in the U.S. in March 2000. Further, these surgical procedures gained popularity, after receiving FDA approvals for various implants such as ProDisc-L, the Bryan, Prestige and ProDisc-C. Later, in 2015, Aesculap Implant Systems received FDA approval for activL artificial disc, for the treatment of one-level lumbar degenerative disc disease. Advent of technology in artificial disc replacement procedures and availability of FDA approved advanced implants, led to its increased adoption among patients with herniated and degenerative discs. Moreover, development of technologically advanced discs such as Mobi-C cervical disc prosthesis for multi-level reconstruction (C3-C7) has increased the product demand over the recent years. Growing inclination towards artificial disc replacement as an alternative to spinal fusion surgery for healing of degenerative discs will offer several growth opportunities in the foreseeable future.